GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Total Inventories

Genetron Holdings (Genetron Holdings) Total Inventories : $8.22 Mil (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Total Inventories?

Genetron Holdings's total inventories for the quarter that ended in Jun. 2022 was $8.22 Mil. Genetron Holdings's average total inventories from the quarter that ended in Mar. 2022 to the quarter that ended in Jun. 2022 was $7.50 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Genetron Holdings's Net-Net Working Capital per share for the quarter that ended in Jun. 2022 was $1.59.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Genetron Holdings's Days Inventory for the three months ended in Jun. 2022 was 56.09.

Inventory Turnover measures how fast the company turns over its inventory within a year. Genetron Holdings's Inventory Turnover for the quarter that ended in Jun. 2022 was 1.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Genetron Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2022 was 0.36.


Genetron Holdings Total Inventories Historical Data

The historical data trend for Genetron Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Total Inventories Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Inventories
Get a 7-Day Free Trial 3.14 2.55 3.82 5.59 6.09

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.45 5.59 6.78 8.22 6.09

Genetron Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Genetron Holdings  (NAS:GTH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Genetron Holdings's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2022 is

Net-Net Working Capital Per Share (Q: Jun. 2022 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(70.6+0.75 * 46.161+0.5 * 8.218-61.005
-0-0.444)/30.2008
=1.59

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Genetron Holdings's Days Inventory for the three months ended in Jun. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2022 )/Cost of Goods Sold (Q: Jun. 2022 )*Days in Period
=7.497/12.196*365 / 4
=56.09

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Genetron Holdings's Inventory Turnover for the quarter that ended in Jun. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2022 ) / Average Total Inventories (Q: Jun. 2022 )
=12.196 / 7.497
=1.63

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Genetron Holdings's Inventory to Revenue for the quarter that ended in Jun. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=7.497 / 20.574
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Genetron Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.

Genetron Holdings (Genetron Holdings) Headlines